In an early Christmas gift to some, Chile and Mexico began vaccination Thursday after issuing an emergency license for the Pfizer / BioNTech vaccine. But in Brazil, where the Covid-19 death toll is much higher, rescue inoculation could be out of reach for months – the country’s Ministry of Health announced last week that its vaccine in February 2021.
Given Brazil ‘s strong history of vaccinations across the country, she says Brazilians were widely expected to have a regional advantage in the fight against the pandemic.
“Brazil has always been at the forefront of implementing new vaccines. We manage to achieve high vaccine coverage, even though it is a continental country with very different regions, such as São Paulo with high population density and Amazonas, with great distances, (and) indigenous population, ”she said.
“People expected a Brazilian vaccination program to start earlier,” she said. But “other countries in America that have prepared themselves are already starting to be vaccinated, and Brazil has been left behind.
With more than 7.4 million people diagnosed with Covid-19 in Brazil and new versions of the virus appearing abroad, there is little reason to think that the pandemic is declining – a claim made by Bolsonaro again this year, even as things continued to go up. in the country. Only the USA and India have reported more coronavirus diseases than Brazil.
The Brazilian President also made headlines last week with a rural effort to cast doubt on the possible side effects of the Pfizer vaccine. “If you become a crocodile, that’s your problem,” he warned. “If you become a Superman, or if you grow a beard like a woman, or if a man ‘s voice grows loud, I have nothing to do with that … or worse, undermine people’ s immune systems.”
Pfizer did not respond to CNN’s request for comment.
Domingues believes Brazil’s federal government was caught unprepared for the use of the Pfizer / BioNTech vaccine, after throwing its support behind a vaccine candidate with Oxford University and AstraZeneca, which has partnered with the local foundation Fiocruz. According to a statement released last week by the Ministry of Health, Brazil has agreed to receive more than 100 million doses of that vaccine, which is still in development.
At the same time there are fears of political influence on the process, after a year of bitter conflict between Bolsonaro and state governors over the country ‘s pandemic response.
The President made no secret that he would prefer to give the Oxford / AstraZeneca vaccine to a vaccine developed by Chinese manufacturer Sinovac Biotech, with support from the state of Sao Paulo and in development to -local with the Brazilian laboratory of the Butantan Institute.
ANVISA and the Brazilian Ministry of Health did not respond to requests for comment.
Statement provided by Tatiana Arias, Jennifer Z. Deaton, Natalie Gallon and Stefano Pozzebon.